Search Results

Answers to the most frequently asked questions about Clinical Trials.

https://www.csl.com/research-and-development/clinical-studies/clinical-studies-faqs

There are a lot of important things to think about before deciding to participate in a trial.

https://www.csl.com/research-and-development/clinical-studies/how-to-participate

CSL's clinical trials are one of the most important steps in the years-long process of obtaining approval for new medications.

https://www.csl.com/research-and-development/clinical-studies

CSL conducts clinical trials on all of its products. See if one of our current clinical trials might be right for you.

https://www.csl.com/research-and-development/clinical-studies/current-clinical-trials

CSL conducts clinical trials in accordance with our Code of Responsible Business Practice and the current Guideline for Good Clinical Practice (GCP) of the International Conference on Harmonization (ICH).

https://www.csl.com/research-and-development/clinical-studies/research-practices

Thanks to patient advisory boards, CSL is continuously learning how to partner with patients and make clinical trials less burdensome.

https://www.csl.com/we-are-csl/vita-original-stories/2024/5-ways-were-making-clinical-trials-better-for-patients-and-care-partners

Clinical Trials Day Is May 20. Follow the journey of a potential treatment through four important phases.

https://www.csl.com/we-are-csl/vita-original-stories/2023/infographic-what-is-a-clinical-trial

CSL and CliniSpan Health partnered on a large-scale survey in 2023 to better understand generational differences related to health care experiences. This research project offers insights to make clinical trials and education more accessible to this under-represented population.

https://www.csl.com/we-are-csl/vita-original-stories/2024/increasing-equity-in-health-care-access-and-clinical-trial-participation-among-african-americans

Sparsentan was well-tolerated with a consistent safety profile across all clinical trials conducted to date and comparable to irbesartan

https://newsroom.csl.com/2023-05-02-Topline-Results-from-Two-Year-Primary-Efficacy-Endpoint-in-Pivotal-Phase-3-DUPLEX-Study-of-Sparsentan-in-Focal-Segmental-Glomerulosclerosis

Nephrology and Clinical Immunology at the University Hospital, RWTH Aachen, Germany, and steering committee member for the PROTECT clinical trial. "

https://newsroom.csl.com/2024-04-24-CSL-Vifor-and-Travere-Therapeutics-Announce-European-Commission-approves-FILSPARI-R-sparsentan-for-the-treatment-of-IgA-Nephropathy